Dr. Gunn is renowned for his successful leadership and contributions to the global animal health and pharmaceutical industries.
Until January 2015, he was Division Head of Novartis Animal Health and a member of the Novartis Executive Committee. Dr. Gunn joined Novartis in 2003 as Head of Novartis Animal Health, North America and became global head of the Animal Health Business Unit in 2004. In addition to this role, he was Division Head, Novartis Consumer Health, from 2008 to 2011 and served as Head of Corporate Social Responsibility from 2011 to 2014.
Before joining Novartis, Dr. Gunn was president of U.S. based Pharmacia Animal Health. His previous positions included a succession of healthcare executive roles over the course of 18 years for leading animal health and pharmaceutical firms including Johnson & Johnson, Pharmacia and, Coopers Animal Health Ltd. Additionally, Dr. Gunn practiced nine years as a veterinary surgeon.
Dr. Gunn graduated with a bachelor of veterinary medicine and surgery from the Royal (Dick) School of Veterinary Studies in the United Kingdom in 1973 and received a diploma in veterinary state medicine from the same school in 1978. In 2008, he received an honorary doctorate in veterinary medicine and surgery from the University of Edinburgh where he was appointed Regent. Dr. Gunn is past Chairman of the UK National Office of Animal Health and the global animal health industry association, the International Federation of Animal Health (IFAH) . Dr. Gunn is a recipient of the Pharmacia Chairman’s Leadership award, the Novartis Chairman’s award for talent development and a special award from the IFAH for his contribution to the industry.
Dr. Gunn founded Stonehaven Consulting AG, an industry consulting firm in which he remains active. He currently serves on the Board of Directors for Philbro Animal Health Corporation and Pharmaq AS and as Chairman of the Board at Nexvet Biopharma Pty Ltd.